3 things to know about Moderna’s mRNA flu vaccine and its FDA application @JohnsHopkinsSPH
3 things to know about Moderna’s mRNA flu vaccine and its FDA application @JohnsHopkinsSPH
Uploaded February 2026 | Updated September 2026, 2 hours ago
Reversing course on its surprise refusal to review Moderna’s mRNA flu vaccine, the FDA has now agreed to consider the company’s application.

Jessica Malaty Rivera breaks down what the news means and outlines concerns from the flip-flop decision.

For more information about mRNA vaccines: https://publichealth.jhu.edu/2025/risks-of-cuts-to-mrna-vaccine-development

https://publichealth.jhu.edu
instagram.com/JohnsHopkinsSPH
facebook.com/JohnsHopkinsSPH
twitter.com/johnshopkinssph
3 things to know about Moderna’s mRNA flu vaccine and its FDA application599 - Book Club—“Under the Skin: The Hidden Toll of Racism on American Lives and the Health...Online Sports BettingExpert Briefing on Ticks and Lyme Disease | May 29, 2025590 - Fatbergs Can Dance!? Behind The Scenes Of A Public Health Water Ballet¿Deberían los niños en los Estados Unidos todavía vacunarse contra el sarampión? #shortsMedia Briefing: mRNA VaccinesAnswering common questions about autism. #shortsWhile summer feels like its over, tick season isnt.574 - The Earthquake in Syria and TurkeyDisability advocate Demi Eckhoff speaks out on Medicaid cuts608 - What May Happen When the COVID-19 Public Health Emergency Ends on May 11
Johns Hopkins Bloomberg School of Public Health |

3 things to know about Moderna’s mRNA flu vaccine and its FDA application

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER